Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Stryker Corporation $SYK

Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in shares of Stryker Corporation (NYSE:SYK) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,007 shares of the medical technology company’s stock, valued at approximately $1,760,000.

Several other large investors have also recently made changes to their positions in SYK. Tredje AP fonden increased its stake in shares of Stryker by 32.0% in the fourth quarter. Tredje AP fonden now owns 131,561 shares of the medical technology company’s stock worth $46,240,000 after buying an additional 31,861 shares during the period. Handelsbanken Fonder AB increased its stake in shares of Stryker by 13.5% in the fourth quarter. Handelsbanken Fonder AB now owns 320,001 shares of the medical technology company’s stock worth $112,471,000 after buying an additional 37,947 shares during the period. AMF Tjanstepension AB increased its stake in shares of Stryker by 7.8% in the fourth quarter. AMF Tjanstepension AB now owns 187,059 shares of the medical technology company’s stock worth $65,746,000 after buying an additional 13,524 shares during the period. Profund Advisors LLC increased its stake in shares of Stryker by 24.2% in the fourth quarter. Profund Advisors LLC now owns 5,766 shares of the medical technology company’s stock worth $2,027,000 after buying an additional 1,122 shares during the period. Finally, ProShare Advisors LLC increased its stake in shares of Stryker by 8.4% in the fourth quarter. ProShare Advisors LLC now owns 65,383 shares of the medical technology company’s stock worth $22,980,000 after buying an additional 5,047 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.45, for a total transaction of $992,075.00. Following the sale, the vice president owned 177 shares in the company, valued at approximately $50,170.65. The trade was a 95.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. UBS Group decreased their target price on shares of Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 17th. TD Cowen downgraded shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price on the stock. in a research note on Monday, January 26th. Leerink Partners assumed coverage on shares of Stryker in a research note on Monday, April 13th. They issued an “outperform” rating and a $410.00 target price on the stock. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Stryker in a report on Friday, May 1st. Finally, Evercore set a $355.00 price target on shares of Stryker in a report on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Stock Performance

NYSE:SYK opened at $313.48 on Friday. The stock has a market cap of $120.17 billion, a P/E ratio of 36.28, a price-to-earnings-growth ratio of 2.03 and a beta of 0.80. The firm’s fifty day simple moving average is $325.81 and its 200 day simple moving average is $350.06. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). The company had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, research analysts predict that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.88 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s payout ratio is 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.